140 related articles for article (PubMed ID: 35677163)
21. Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8
Shuai C; Yang X; Pan H; Han W
Front Oncol; 2020; 10():582863. PubMed ID: 33102239
[No Abstract] [Full Text] [Related]
22. Integrative Dissection of Novel Lactate Metabolism-Related Signature in the Tumor Immune Microenvironment and Prognostic Prediction in Breast Cancer.
Yang L; Tan P; Sun H; Zeng Z; Pan Y
Front Oncol; 2022; 12():874731. PubMed ID: 35574387
[TBL] [Abstract][Full Text] [Related]
23. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
24. Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database.
Yang H; Zhao K; Kang H; Wang M; Wu A
Medicine (Baltimore); 2020 Apr; 99(14):e19561. PubMed ID: 32243373
[TBL] [Abstract][Full Text] [Related]
25. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.
Du F; Zheng F; Han Y; Zhao J; Yuan P
Front Pharmacol; 2022; 13():820437. PubMed ID: 35721151
[No Abstract] [Full Text] [Related]
26. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
Okano M; Oshi M; Butash AL; Katsuta E; Tachibana K; Saito K; Okayama H; Peng X; Yan L; Kono K; Ohtake T; Takabe K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461932
[TBL] [Abstract][Full Text] [Related]
27. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
28. Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer.
Wu R; Yu I; Tokumaru Y; Asaoka M; Oshi M; Yan L; Okuda S; Ishikawa T; Takabe K
Am J Cancer Res; 2022; 12(11):5271-5285. PubMed ID: 36504906
[TBL] [Abstract][Full Text] [Related]
29. Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue.
Quigley DA; Tahiri A; Lüders T; Riis MH; Balmain A; Børresen-Dale AL; Bukholm I; Kristensen V
Oncoimmunology; 2017; 6(11):e1356142. PubMed ID: 29147603
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
[TBL] [Abstract][Full Text] [Related]
31. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.
Zhong Y; Zhuang Z; Mo P; Lin M; Gong J; Huang J; Mo H; Lu Y; Huang M
PeerJ; 2021; 9():e12506. PubMed ID: 34993016
[TBL] [Abstract][Full Text] [Related]
33. High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer.
Takeshita T; Asaoka M; Katsuta E; Photiadis SJ; Narayanan S; Yan L; Takabe K
Am J Transl Res; 2019; 11(10):6507-6521. PubMed ID: 31737202
[TBL] [Abstract][Full Text] [Related]
34. Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC).
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Kalinski P; Endo I; Takabe K
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198125
[TBL] [Abstract][Full Text] [Related]
35. CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.
Shehwana H; Keskus AG; Ozdemir SE; Acikgöz AA; Biyik-Sit R; Cagnan I; Gunes D; Jahja E; Cingir-Koker S; Olmezer G; Sucularli C; Konu O
Cell Oncol (Dordr); 2021 Apr; 44(2):453-472. PubMed ID: 33469842
[TBL] [Abstract][Full Text] [Related]
36. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
Okano M; Oshi M; Butash AL; Asaoka M; Katsuta E; Peng X; Qi Q; Yan L; Takabe K
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151151
[TBL] [Abstract][Full Text] [Related]
37. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
PeerJ; 2021; 9():e12276. PubMed ID: 34721975
[TBL] [Abstract][Full Text] [Related]
39. High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Tokumaru Y; Katsuta E; Oshi M; Sporn JC; Yan L; Le L; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357442
[TBL] [Abstract][Full Text] [Related]
40. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling.
Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B
Front Immunol; 2022; 13():859581. PubMed ID: 35795662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]